Anti-atherogenic Effects of Soybean (Glycine max) Seed and Ginger (Zingiber officinale) Rhizome Extracts on Type 2 Diabetic Rat Model
Keywords:
Antiatherogenic, Diabetes mellitus, Glycine max, Soybean, Zingiber officinaleAbstract
Diabetes mellitus (DM) is linked to an increase in dyslipidemia, which is associated with atherosclerosis, one of the leading causes of cardiovascular disease. Soybean (Glycine max) and ginger (Zingiber officinale) are functional foods, although the potency of herbs to suppress atherogenic DM has not been adequately demonstrated. This study was therefore conducted to examine the anti-atherogenic effects of G. max, Z. officinale, and their combination in a type 2 diabetic rat model. Extracts were prepared from G. max seeds and Z. officinale rhizome. Sprague Dawley rats were obtained and given a combination of high fructose high lipid diet (HFHLD) and a single dose of streptozotocin (25 mg/kg BW) intraperitoneally to induce diabetes. The rats were administered orally with G. max (5000 mg/kg BW), Z. officinale (500 mg/kg BW), and their combination for four weeks. Blood samples were collected from the heart. The lipid profile was calculated to determine the amounts of non-HDL-c, CRI-1 (TC/HDL-c), CRI-2 (LDLc/HDLc), and AIP [log 10 (TG/HDL-c)]. The results revealed that the oral administration of G. max (5000 mg/kg BW), Z. officinale (500 mg/kg BW), and their combination significantly (p<0.05) lowered non-HDL cholesterol levels by 20, 40, and 50%, respectively, compared to the diabetic group, while AIP levels were reduced significantly (p<0.05) by 20, 30, and 30%, respectively. CRI-2 was significantly (p<0.05) lowered by 30% in all test groups, but only Z. officinale reduced CRI-1. The findings of this study show that Z. officinale is more effective at inhibiting atherogenesis than G. max and their combination.
References
Darmono ST, Pemayun TGD, Padmomartono FS. Complete manuscript of diabetes mellitus reviewed from various aspects of Internal Medicine. Semarang Publisher, University of Diponegoro. 2007; 1:2-5.
Fan W. Epidemiology in diabetes mellitus and cardiovascular disease. Cardiovasc Endocrinol. 2017; 6(1):8-16.
Ma'rufi R and Rosita L. Correlation between dyslipidemia and the incidence of coronary heart disease. J Kedokteran dan Kesehatan Indon. 2014; 6(1):1-7.
Smeltzer SC and Bare BG. Smeltzer and Bare`s Textbook of Medical Surgical Nursing Vol. 2. Philadelphia: Lippincott Williams & Wilkins. 2008;
:200-215.
Guyton AC and Hall JE. Textbook of Medical Physiology. 12th ed. Jakarta: EGC. 2014; 12:325-360.
Schofield JD, Liu Y, Rayaz PR. Diabetes dyslipidemia. Diabetes therapy. 2016; 7(2):1-17.
Ashen MD and Blumenthal RS. Low HDL Cholesterol levels. New Engl J Med. 2005; 353(12):1252-1260.
Mustofa MS, Mukhtar D, Susmiarsih T, Kunci K. Effect of Soybean (Glycine max (L) Merril) on Blood Glucose Levels and Insulin Expression of Pancreatic β Cells in. Jurnal Kedokteran Yarsi. 2010; 18(2):94-103.
Villegas R, Gao Y, Yang G, Li H, Elasy TA, Zheng W, Shu XO. Legume and soy food intake and the incidence of type 2 diabetes in the Shanghai Women’s health study. Am J Clin Nutr. 2018; 87(1):162-167.
Tzi Bun. Soybean-Biochemistry, Chemistry, and Physiology. Croatia: In Tech. 2011; 1:25-30.
Purnomo Y. Potential oral glucose tolerance of soybean seed extract (Glycine max), ginger rhizome (Zingiber officinale) and their combination in diabetic rat model. JKesehatan Islam. 2018; 7(2):45-50.
Nammi S, Sreemantula S, Roufogalis BD. Protective Effects of Ethanolic Extract of Zingiber officinale rhizome on the development of metabolic syndrome in high-fat dietfed rats. Basic Clin Pharmacol. 2009; 104(5):366-373.
Yanto AR, Nurul M, Susetyorini E. Steeping of Ginger (Zingiber Officinale Rosce) lowers blood glucose in rat model Type-2 diabetes (NIDDM) as a learning resource Biology. J Pendidikan Biologi Indonesia. 2016; 2(3):258-264.
Shirwaikar A, Rajendran K, Barik R. Effect of aqueous bark extract of Garuga pinnata Roxb in streptozotocinnicotinamide induced Type-II diabetes mellitus. J Ethnopharmacol. 2006; 107(2):285-290.
Alain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974; 20(4):470-475.
Bhardwaj S, Bhattacharjee J, Bhatnagar M, Tyagi S. Atherogenic index of plasma, castelli risk index and atherogenic coefficient-new parameters in assessing cardiovascular risk. Int J Pharma and Bio Sci. 2013; 3(1):359-364.
Dobiásová M and Frohlich J. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoBlipoprotein-depleted plasma (FER(HDL)). Clin Biochem. 2001; 34(7):583-588.
Mezei O, Banz WJ, Steger RW, Peluso MR, Winters TA, Shay N. Biochemical and molecular actions of nutrients soy isoflavones exert antidiabetic and hypolipidemic effects through the PPAR pathways in obese Zucker rats and murine RAW 2647 cells. J Nutr. 2003; 133(5):1238-1243.
Franz M. Medical nutrition therapy for diabetes mellitus and hypoglycemia of nondiabetic origin. In: Krause's Food and the Nutrition Care Process. 13th ed., Elsevier, Saunders. 2012; 675-710p.
Purnomo Y, Taufiq M, Wijaya AND, Hakim R. Molecular docking of soybean (Glycine max) seed and ginger (Zingiber officinale) rhizome as anti-diabetic through inhibition of dipeptidyl peptidase-4 (DPP-4) and alphaglucosidase enzymes. Trop J Nat Prod Res. 2021; 5(10):1735-1742.
Purnomo Y, Soeatmadji DW, Sumitro SB, Widodo MA. Anti hyperglycemic effect of Urena lobata leaf extract by inhibition of dipeptidyl peptidase IV (DPP-IV) on diabetic rats. Int J Pharmacogn Phytochem Res. 2015; 7:1073-1079.
Purnomo Y, Soeatmadji DW, Sumitro SB, Widodo MA. Inhibitory activity of Urena lobata leaf extract on dipeptidyl peptidase-4 (DPP-4): is it different in vitro and in vivo?. Med Plants. 2018; 10(2):99-105.
Al-azhary DB. Ginger enhances antioxidant activity and attenuates atherogenesis in diabetic cholesterol-fed rats. Austr J Basic Appl Sci. 2011; 5(12):2150-2158.
Kusumaningati RW. Analysis of phenolic compound of ginger (Zingiber officinale Roscoe) in vitro. Medical Education Program, Faculty of Medicine. University of Indonesia. 2009; 1:3-6.
Handayani W, Lyrawati D, Andarini S, Rudijanto A. Effect of the combination of soy milk and ginger on increasing insulin sensitivity in insulin resistance rats model (in silico and in vivo studies). Dissertation of Doctoral Program in Medical Sciences. Faculty of Medicine University of Brawijaya. 2018; 1:4-10.
Dugasani S, Pichika MR, Nadarajah VD, Balijepalli MK, Tandra S, Korlakunta JN. [8]-gingerol, [10]-gingerol and [6]-shogaol. J Ethnopharmacol. 2010; 127(126):515–520.
Li Y, Tran VH, Duke CC, Roufogalis BD. Preventive and protective properties of Zingiber officinale (ginger) in diabetes mellitus, diabetic complications and associated lipid and other metabolic disorders : A brief review. EvidBased Compl Altern Med. 2012; 1(1):1-10.
Kang M, Hirai S, Goto T, Kuroyanagi K, Kim Y, Ohyama K, et al. Dehydroabietic acid, a diterpene, improves diabetes and hyperlipidemia in obese diabetic KK-Ay mice. Bio Factors. 2009; 35(5):422-448.
Lichtenstein AH. Recent advances in nutritional science soy protein, isoflavones and cardiovascular disease risk. J Nutr. 1998; 128(10):1589-1592.
Al-amin ZM, Thomson M, Al-qattan KK, Peltonen-shalaby R, Ali M. Anti-diabetic and hypolipidaemic properties of ginger (Zingiber officinale) in streptozotocin-induced diabetic rats. Br J Nutr. 2006; 96(4):660–666.
Hey SJ, Powers SJ, Beale MH, Hawkins ND, Ward JL, Halford NG. Enhanced seed phytosterol accumulation through expression of a modified HMG-CoA reductase. Plant Biotech J. 2006; 4(2):219-229.
Rani M, Cherian L, Sciences N. Inhibitory potential of ginger extracts against enzymes linked to type 2 diabetes, inflammation and induced oxidative stress inhibitory potential of ginger extracts against enzymes linked to Type 2 diabetes, inflammation and induced oxidative stress. Int J Food Sci Nutr. 2011; 62(2):106-110.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
